Design, synthesis and characterization of ethyl 3‐benzoyl‐7‐morpholinoindolizine‐1‐carboxylate as anti‐tubercular agents: In silico screening for possible target identification

Documenti analoghi

• Synthesis, characterization, and anti‐inflammatory properties of novel ethyl 3‐benzoyl‐7‐(trifluoromethyl)indolizine‐1‐carboxylate derivatives: In silico and in vitro analysis
  di: Harshada Rambaboo Singh, et al.
  Pubblicazione: (2024)
• Design, synthesis, in silico molecular docking, and ADMET studies of quinoxaline‐isoxazole‐piperazine conjugates as EGFR‐targeting agents
  di: Mohammad Imtiyaz Ali, et al.
  Pubblicazione: (2024)
• Metabolite markers for three synthetic tryptamines N‐ethyl‐N‐propyltryptamine, 4‐hydroxy‐N‐ethyl‐N‐propyltryptamine, and 5‐methoxy‐N‐ethyl‐N‐propyltryptamine
  di: Marianne Skov‐Skov Bergh, et al.
  Pubblicazione: (2024)
• Design, synthesis, in silico, and in vitro evaluation of novel benzyloxybenzene substituted (S)‐α‐amino amide derivatives as cholinesterases and monoaminoxidases inhibitor
  di: Akın Akıncıoğlu
  Pubblicazione: (2024)
• Design, synthesis, and biological evaluation of novel quinoxaline aryl ethers as anticancer agents
  di: Srinuvasu Nakka, et al.
  Pubblicazione: (2024)